181 related articles for article (PubMed ID: 35361160)
21. Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Ohata K; Sugaya T; Nguyen HN; Arai K; Hatanaka Y; Uno K; Tohma M; Uechi T; Sekiguchi K; Oikawa T; Nagabukuro H; Kuniyeda K; Kamijo-Ikemori A; Suzuki-Kemuriyama N; Nakae D; Noiri E; Miyajima K
Nephrology (Carlton); 2024 Mar; 29(3):117-125. PubMed ID: 37950597
[TBL] [Abstract][Full Text] [Related]
22. The role of urinary liver-type fatty acid-binding protein in critically ill patients.
Cho E; Yang HN; Jo SK; Cho WY; Kim HK
J Korean Med Sci; 2013 Jan; 28(1):100-5. PubMed ID: 23341719
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
24. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care.
Doi K; Noiri E; Sugaya T
Curr Opin Crit Care; 2010 Dec; 16(6):545-9. PubMed ID: 20736829
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil gelatinase-associated lipocalin and liver-type fatty acid-binding protein as biomarkers for acute kidney injury after organ transplantation.
Iguchi N; Uchiyama A; Ueta K; Sawa Y; Fujino Y
J Anesth; 2015 Apr; 29(2):249-55. PubMed ID: 25205293
[TBL] [Abstract][Full Text] [Related]
26. Quantitative and qualitative analyses of urinary L-FABP for predicting acute kidney injury after emergency laparotomy.
Okuda H; Obata Y; Kamijo-Ikemori A; Inoue S
J Anesth; 2022 Feb; 36(1):38-45. PubMed ID: 34716487
[TBL] [Abstract][Full Text] [Related]
27. Novel Urinary Biomarkers for Acute Kidney Injury and Prediction of Clinical Outcomes After Pediatric Cardiac Surgery.
Yoneyama F; Okamura T; Takigiku K; Yasukouchi S
Pediatr Cardiol; 2020 Apr; 41(4):695-702. PubMed ID: 31872282
[TBL] [Abstract][Full Text] [Related]
28. Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function.
Siew ED; Ware LB; Bian A; Shintani A; Eden SK; Wickersham N; Cripps B; Ikizler TA
Kidney Int; 2013 Oct; 84(4):786-94. PubMed ID: 23698227
[TBL] [Abstract][Full Text] [Related]
29. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.
Krawczeski CD; Goldstein SL; Woo JG; Wang Y; Piyaphanee N; Ma Q; Bennett M; Devarajan P
J Am Coll Cardiol; 2011 Nov; 58(22):2301-9. PubMed ID: 22093507
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
31. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study.
Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P
Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275
[TBL] [Abstract][Full Text] [Related]
32. Assessment of subclinical acute kidney injury after abdominal aortic aneurysm surgery using novel markers: L-FABP and H-FABP.
Kokot M; Biolik G; Ziaja D; Fojt T; Kędzierski L; Antoniak K; Janowska M; Pawlicki K; Ziaja K; Duława J
Nefrologia; 2014; 34(5):628-36. PubMed ID: 25259818
[TBL] [Abstract][Full Text] [Related]
33. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
34. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.
Parr SK; Clark AJ; Bian A; Shintani AK; Wickersham NE; Ware LB; Ikizler TA; Siew ED
Kidney Int; 2015 Mar; 87(3):640-8. PubMed ID: 25229339
[TBL] [Abstract][Full Text] [Related]
35. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
[TBL] [Abstract][Full Text] [Related]
36. Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.
Connolly M; Kinnin M; McEneaney D; Menown I; Kurth M; Lamont J; Morgan N; Harbinson M
QJM; 2018 Feb; 111(2):103-110. PubMed ID: 29069419
[TBL] [Abstract][Full Text] [Related]
37. Low levels of urinary liver-type fatty acid-binding protein may indicate a lack of kidney protection during aortic arch surgery requiring hypothermic circulatory arrest.
Mori Y; Sato N; Kobayashi Y; Ochiai R
J Clin Anesth; 2014 Mar; 26(2):118-24. PubMed ID: 24582841
[TBL] [Abstract][Full Text] [Related]
38. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.
Portilla D; Dent C; Sugaya T; Nagothu KK; Kundi I; Moore P; Noiri E; Devarajan P
Kidney Int; 2008 Feb; 73(4):465-72. PubMed ID: 18094680
[TBL] [Abstract][Full Text] [Related]
39. Association Of Liver Fatty Acid Binding Protein With Acute Kidney Injury In Paediatric Patients After Cardiac Surgery.
Khan MB; Naseem T; Wazir HD; Ayyub A; Saad AB; Irshad R
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(3):S602-S607. PubMed ID: 36414576
[TBL] [Abstract][Full Text] [Related]
40. Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
Ohata K; Sugaya T; Nguyen HN; Hatanaka Y; Uno K; Tohma M; Oikawa T; Nagabukuro H; Kuniyeda K; Kamijo-Ikemori A; Suzuki-Kemuriyama N; Nakae D; Noiri E; Miyajima K
Nephrology (Carlton); 2023 Jun; 28(6):345-355. PubMed ID: 37076661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
